StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Gilead Sciences (GILD) Data Points are a Positive but An Entry Point may be Coming - Jefferies
April 13, 2020 6:27 AM
Jefferies analyst Michael Yee reiterated a Buy rating and $89.00 price target on Gilead Sciences (NASDAQ: GILD) after the company ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
